R. Dyall et al., CD4-INDEPENDENT IN-VIVO PRIMING OF MURINE CTL BY OPTIMAL MHC CLASS I-RESTRICTED PEPTIDES DERIVED FROM INTRACELLULAR PATHOGENS, International immunology, 7(8), 1995, pp. 1205-1212
CTL combat intracellular pathogens by killing infected cells. The mole
cular targets of their attack are foreign peptides bound to self MHC e
ncoded class I molecules. Immunization of mice with peptides containin
g CTL determinants was shown to elicit CD4-dependent CTL. Here, we hav
e achieved in vivo CTL priming with naturally processed 8-10 amino aci
d long class I-restricted peptides emulsified in an adjuvant. A potent
, reproducible and physiologically relevant response was obtained usin
g peptides from an intracellular bacterium and five Viruses (including
HIV) in two murine MHC haplotypes. This method is suitable for multip
le vaccination, since a 'cocktail' of peptides derived from three path
ogens elicited effector CTL against each pathogen. Most importantly, p
eptide-induced CD8(+)CD4(-) CTL were CD4(+)-independent. These results
have implications for CTL induction in situations where CD4 T cells a
re depleted or compromised, as is the case in HIV infection.